New and Evolving Clinical Trials: Embolotherapy

SIR 2022 Coverage

M. Soulen

Colorectal Liver Metastases: Liver-Directed Therapies - Embolization…

Penn Medicine Abramson Cancer Center

M. Soulen

Interventional Oncology for Colorectal Metastases: Percutaneous Ther…

2021 KUMC Virtual Multidisciplinary Oncology Review

A. Alli

HCC in Intermediate BCLC B: How TACE Affects Median OS? Is TACE/TARE…

Cedars Sinai

J. Marrero, W. C. Maddrey

Liver-Directed Therapy for mCRC: What Is the Goal, When to Use and H…

Memorial Sloan Kettering Cancer Center

A. Cercek

Temporary Occlusion Micro Balloon Catheter in TACE: What Imaging and…

Andrew Holden

2020 Update on GIST Local Treatment Options: How Effective and Safe …

Peter Reichardt

Transarterial Chemoembolization Using 40µm Drug Eluting Beads for He…

Giorgio Greco

Sorafenib with Transarterial Chemoembolization Achieves Improved Sur…

Victor Kok

V. Kok

Transarterial Chemoembolization and Building an IO Practice Discussi…

Deepak Sudheendra

Transradial Drug Eluting Bead Chemoembolization for Liver Cancer usi…

TREAT Symposium

A. Fischman

Radial Access in IO

Symposium on Clinical Interventional Oncology (CIO 2018)

B-TACE MOA Model: Portal Vein and Tumor Pressure Gradient Effect

Yehia El Hgar

Transarterial Embolization for Lung Lesions: Indications, Technique,…

Thomas Vogl

Spinal Tumor Ablation and Vertebral Augmentation for Treatment of Pa…

Douglas Beall

Multidisciplinary Approach to Hepatocellular Carcinoma

UCLA Health

G. Choi, B. Yanny, S. Sadeghi, J. Hui

ESMO 2024 Summary: Highlights in HCC

2024 ESMO Annual Meeting Insights Hub

R. Kim, T. Biachi

Hyperprogression in Cancer Treated With Immunotherapy

Northwestern Medicine Oncology and Hematology

Y. Chae

ESMO 2024 Insights: TACE ± Lenvatinib + Pembro for Int-Stage HCC - P…

2024 ESMO Annual Meeting Insights Hub

J. Llovet